Química médica y biológica - MedChemLab
QUÍMICA MÉDICA
Centro Nacional de Investigaciones Oncológicas
Madrid, EspañaPublications in collaboration with researchers from Centro Nacional de Investigaciones Oncológicas (8)
2023
2020
2019
-
A Potent Isoprenylcysteine Carboxylmethyltransferase (ICMT) Inhibitor Improves Survival in Ras-Driven Acute Myeloid Leukemia
Journal of Medicinal Chemistry, Vol. 62, Núm. 13, pp. 6035-6046
-
Essentiality of fatty acid synthase in the 2D to anchorage-independent growth transition in transforming cells
Nature Communications, Vol. 10, Núm. 1
2017
-
Multi-level suppression of receptor-PI3K-mTORC1 by fatty acid synthase inhibitors is crucial for their efficacy against ovarian cancer cells
Oncotarget, Vol. 8, Núm. 7, pp. 11600-11613
2015
-
Fatty acid synthase is a metabolic marker of cell proliferation rather than malignancy in ovarian cancer and its precursor cells
International Journal of Cancer, Vol. 136, Núm. 9, pp. 2078-2090
-
Role of cannabinoid receptor CB<inf>2</inf> in HER2 pro-oncogenic signaling in breast cancer
Journal of the National Cancer Institute, Vol. 107, Núm. 6
2012
-
New synthetic inhibitors of fatty acid synthase with anticancer activity
Journal of Medicinal Chemistry, Vol. 55, Núm. 11, pp. 5013-5023